{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:02:12Z","timestamp":1785769332123,"version":"3.56.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    We present\n                    <jats:sup>18<\/jats:sup>\n                    F-FAPI-74 PET\/CT findings before and after proton beam therapy (PBT) in a 71-year-old woman with liver metastasis following pancreatic cancer resection. Before PBT, no uptake was observed on FDG-PET, whereas the lesion was visualized on FAPI-PET, consistent with contrast-enhanced MRI. Follow-up FAPI-PET at 3 and 6 months post-PBT revealed mild, newly developed uptake confined to the high-dose irradiated area. However, contrast-enhanced MRI demonstrated complete tumor disappearance and normalization of serum tumor marker levels. These findings suggest that post-irradiation\n                    <jats:sup>18<\/jats:sup>\n                    F-FAPI-74 uptake is more likely attributable to reactive changes, such as radiation-induced hepatic fibrosis, rather than residual or recurrent tumor.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006448","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:00:31Z","timestamp":1775750431000},"page":"630-631","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Potential Role of 18F-FAPI-74 PET\/CT in Proton Beam Therapy for Liver Metastasis: Clinical Insights and Limitations"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-9416","authenticated-orcid":false,"given":"Shinya","family":"Komori","sequence":"first","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama"},{"name":"Department of Radiation Physics and Technology, Southern Tohoku BNCT Research Center, Koriyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, Koriyama"},{"name":"School of Health Sciences, Fukushima Medical University, Fukushima"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Momose","sequence":"additional","affiliation":[{"name":"Department of Biofunctional Imaging, Fukushima Medical University, Fukushima"},{"name":"Department of Radiology, Southern Tohoku Drug Discovery and Cyclotron Research Center, Koriyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Southern Tohoku Proton Therapy Center, Koriyama, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"R1-20260605","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"R2-20260605","doi-asserted-by":"crossref","first-page":"e220749","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"key":"R3-20260605","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET\/CT in cancer patients","volume":"48","author":"Giesel","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20260605","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2967\/jnumed.123.265486","article-title":"Initial evaluation of [18F]FAPI-74 PET for various histopathologically confirmed cancers and benign lesions","volume":"64","author":"Watabe","year":"2023","journal-title":"J Nucl Med"},{"key":"R5-20260605","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40644-023-00626-y","article-title":"Head-to-head comparison of 18F-FAPI and 18F-FDG PET\/CT in staging and therapeutic management of hepatocellular carcinoma","volume":"23","author":"Zhang","year":"2023","journal-title":"Cancer Imaging"},{"key":"R6-20260605","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1470-2045(25)00299-2","article-title":"[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial","volume":"26","author":"Pabst","year":"2025","journal-title":"Lancet Oncol"},{"key":"R7-20260605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13014-025-02606-x","article-title":"FAPI-PET\/CT guided radiotherapy for patients with esophageal cancer","volume":"20","author":"Kr\u00f6ger","year":"2025","journal-title":"Radiat Oncol"},{"key":"R8-20260605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2021.02.015","article-title":"68Ga-fibroblast activation protein inhibitor PET\/CT on gross tumour volume delineation for radiotherapy planning of oesophageal cancer","volume":"158","author":"Zhao","year":"2021","journal-title":"Radiother Oncol"},{"key":"R9-20260605","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1038\/emm.2017.85","article-title":"Radiation-induced liver disease: current understanding and future perspectives","volume":"49","author":"Kim","year":"2017","journal-title":"Exp Mol Med"},{"key":"R10-20260605","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11604-018-0728-1","article-title":"Pathology and images of radiation-induced hepatitis: a review article","volume":"36","author":"Takamatsu","year":"2018","journal-title":"Jpn J Radiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:06:15Z","timestamp":1785765975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006448","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"2026-01-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}